Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix

Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute life-threatening variant of DIC in patients with prostate cancer. Patients present with coagulopathy, hypofibrinogenemia, and systemic bleeding. We describe a case of DIC XFL caused by prostate cancer...

Full description

Saved in:
Bibliographic Details
Main Authors: Shawn Y. Ong, Josephine Taverna, Clint Jokerst, Thomas Enzler, Emad Hammode, Elisa Rogowitz, Myke R. Green, Hani M. Babiker
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2015/212543
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567008033505280
author Shawn Y. Ong
Josephine Taverna
Clint Jokerst
Thomas Enzler
Emad Hammode
Elisa Rogowitz
Myke R. Green
Hani M. Babiker
author_facet Shawn Y. Ong
Josephine Taverna
Clint Jokerst
Thomas Enzler
Emad Hammode
Elisa Rogowitz
Myke R. Green
Hani M. Babiker
author_sort Shawn Y. Ong
collection DOAJ
description Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute life-threatening variant of DIC in patients with prostate cancer. Patients present with coagulopathy, hypofibrinogenemia, and systemic bleeding. We describe a case of DIC XFL caused by prostate cancer (PC) successfully treated with a single injection of degarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist. This led to prompt control of the patient’s coagulopathy within ten days of treatment. Our case highlights features of this rare and devastating hemorrhagic complication of PC along with a fast-acting and effective therapeutic drug option.
format Article
id doaj-art-6ca10420f43f43e9bbd3b0287ccf3b1b
institution Kabale University
issn 2090-6706
2090-6714
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-6ca10420f43f43e9bbd3b0287ccf3b1b2025-02-03T01:02:35ZengWileyCase Reports in Oncological Medicine2090-67062090-67142015-01-01201510.1155/2015/212543212543Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with DegarelixShawn Y. Ong0Josephine Taverna1Clint Jokerst2Thomas Enzler3Emad Hammode4Elisa Rogowitz5Myke R. Green6Hani M. Babiker7University of Arizona College of Medicine, 1501 N. Campbell Avenue, Tucson, AZ 85724, USAUniversity of Arizona Cancer Center, 1515 N Campbell Avenue, Tucson, AZ 85724, USADepartment of Radiology, University of Arizona College of Medicine, 1501 N. Campbell Avenue, Tucson, AZ 85724, USADepartment of Medicine, University of Arizona College of Medicine, 1501 N. Campbell Avenue, RM 6336, Tucson, AZ 85724, USADepartment of Medicine, University of Arizona College of Medicine, 1501 N. Campbell Avenue, RM 6336, Tucson, AZ 85724, USAScripps Health, Department of Medicine, 10666 N Torrey Pines Road, La Jolla, CA 92037, USADepartment of Pharmacy Services, University of Arizona Medical Center, 1501 N Campbell Avenue, Tucson, AZ 85724, USAUniversity of Arizona Cancer Center, 1515 N Campbell Avenue, Tucson, AZ 85724, USADisseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute life-threatening variant of DIC in patients with prostate cancer. Patients present with coagulopathy, hypofibrinogenemia, and systemic bleeding. We describe a case of DIC XFL caused by prostate cancer (PC) successfully treated with a single injection of degarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist. This led to prompt control of the patient’s coagulopathy within ten days of treatment. Our case highlights features of this rare and devastating hemorrhagic complication of PC along with a fast-acting and effective therapeutic drug option.http://dx.doi.org/10.1155/2015/212543
spellingShingle Shawn Y. Ong
Josephine Taverna
Clint Jokerst
Thomas Enzler
Emad Hammode
Elisa Rogowitz
Myke R. Green
Hani M. Babiker
Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
Case Reports in Oncological Medicine
title Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
title_full Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
title_fullStr Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
title_full_unstemmed Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
title_short Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
title_sort prostate cancer associated disseminated intravascular coagulation with excessive fibrinolysis treated with degarelix
url http://dx.doi.org/10.1155/2015/212543
work_keys_str_mv AT shawnyong prostatecancerassociateddisseminatedintravascularcoagulationwithexcessivefibrinolysistreatedwithdegarelix
AT josephinetaverna prostatecancerassociateddisseminatedintravascularcoagulationwithexcessivefibrinolysistreatedwithdegarelix
AT clintjokerst prostatecancerassociateddisseminatedintravascularcoagulationwithexcessivefibrinolysistreatedwithdegarelix
AT thomasenzler prostatecancerassociateddisseminatedintravascularcoagulationwithexcessivefibrinolysistreatedwithdegarelix
AT emadhammode prostatecancerassociateddisseminatedintravascularcoagulationwithexcessivefibrinolysistreatedwithdegarelix
AT elisarogowitz prostatecancerassociateddisseminatedintravascularcoagulationwithexcessivefibrinolysistreatedwithdegarelix
AT mykergreen prostatecancerassociateddisseminatedintravascularcoagulationwithexcessivefibrinolysistreatedwithdegarelix
AT hanimbabiker prostatecancerassociateddisseminatedintravascularcoagulationwithexcessivefibrinolysistreatedwithdegarelix